» Articles » PMID: 689746

Protective Isolation and Antimicrobial Decontamination in Patients with High Susceptibility to Infection. A Prospective Cooperative Study of Gnotobiotic Care in Acute Leukaemia Patients. III: The Quality of Isolation and Decontamination

Overview
Journal Infection
Date 1978 Jan 1
PMID 689746
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In a cooperative study, the quality of protective isolation and of antibiotic decontamination of the digestive tract was studied in patients with acute leukaemia by (bio)-typing of Enterobacteriaceae species, Pseudomonas aeruginosa and Staphylococcus aureus isolated from oral washings and faecal samples. These samples were collected before and during treatment of 82 patients who were either isolated and decontaminated for which latter purposes a combination of neomycin, polymyxin, bacitracin and nystatin was used (group A); isolated without decontamination (Group B) or treated on the ward without decontamination (Group C). The results indicated that protective isolation had only been completely successful during the entire (remission induction) treatment period in one of the 32 patients in Group B. In Group A patients, who underwent antibiotic decontamination in addition, successful isolation was achieved in 57% of 28 patients. Successful antibiotic decontamination of the digestive tract for the entire treatment period as far as all potentially pathogenic species are concerned, was realized in 4 (14%) of the 28 patients of Group A. Bacteriologically confirmed infections occurred in 50% of Group A patients, in 59% Group B patients and in 64% of Group C patients. It is concluded that the quality of isolation had in general been insufficient but that it was improved by oral nonabsorbable antibiotics and, furthermore, that the antibiotic decontamination procedure also requires improvement.

Citing Articles

Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.

Muis N, Kamps W, Dankert J Support Care Cancer. 1996; 4(3):200-6.

PMID: 8739653 DOI: 10.1007/BF01682341.


E.O.R.T.C. Gnotobiotic Project Group: a prospective cooperative study of antimicrobial decontamination in granulocytopenic patients. Comparison of two different methods.

Infection. 1982; 10(3):131-8.

PMID: 7049955 DOI: 10.1007/BF01640762.


Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

de Vries-Hospers H, Sleijfer D, Mulder N, Van Der Waaij D, Neiweg H, Van Saene H Antimicrob Agents Chemother. 1981; 19(5):813-20.

PMID: 7027923 PMC: 181528. DOI: 10.1128/AAC.19.5.813.


The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia.

Kurrle E, Bhaduri S, Heimpel H, Hoelzer D, Krieger D, Vanek E Blut. 1980; 40(3):187-95.

PMID: 6928791 DOI: 10.1007/BF01008576.


Laminar air flow versus barrier nursing in marrow transplant recipients.

Mahmoud H, Schaefer U, Schuning F, SCHMIDT C, Bamberg M, Haralambie E Blut. 1984; 49(5):375-81.

PMID: 6388667 DOI: 10.1007/BF00319885.


References
1.
Dietrich M, Gaus W, Vossen J, Van Der Waaij D, Wendt F . Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results. Infection. 1977; 5(2):107-14. DOI: 10.1007/BF01642091. View

2.
Klastersky J, Debusscher L, Weerts D, Daneau D . Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains. Pathol Biol (Paris). 1974; 22(1):5-12. View

3.
Van Der Waaij D . Infection by the distribution of biotypes of enterobacteriacease species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe. Infection. 1977; 5(3):188-94. DOI: 10.1007/BF01639756. View

4.
YATES J, HOLLAND J . A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer. 1973; 32(6):1490-8. DOI: 10.1002/1097-0142(197312)32:6<1490::aid-cncr2820320628>3.0.co;2-6. View

5.
Schneider M, SCHWARZENBERG L, AMIEL J, Cattan A, SCHLUMBERGER J, Hayat M . Pathogen-free isolation unit--three years' experience. Br Med J. 1969; 1(5647):836-9. PMC: 1982443. DOI: 10.1136/bmj.1.5647.836. View